Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02475005
Other study ID # 2R44HD066920-03A1
Secondary ID
Status Completed
Phase N/A
First received June 12, 2015
Last updated February 27, 2018
Start date September 20, 2014
Est. completion date November 28, 2017

Study information

Verified date February 2018
Source Inflexxion, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test the efficacy of a new app to help adolescents with chronic or reoccurring headaches self manage pain.


Description:

Headaches dramatically affect adolescents' overall functioning and quality of life. We have developed a highly engaging mobile-based program that will help adolescents to make connections between behaviors and symptoms, and to ultimately improve functioning and quality of life. The mobile-based program will provide a state of the art pain tracker, a variety of coping strategies, and information about self-management of symptoms. This app will offer a maximally engaging way to help adolescents track their pain, make connections between lifestyle and pain, and learn key self-management skills.

The study involves the participant being randomized into either the experimental group, where he/she will be using this mobile application to track their headache symptoms, or the control group, where he/she will receive headache treatment as usual; the control group will not be using an app for this study. The intervention will last for two months.

Participants will be assessed at baseline, at 2-months post baseline, at 3-months post baseline, and at 6-months post baseline. All participants will be asked to complete online questionnaires about their headaches. We plan to enroll 144 adolescent participants with headaches, as well as one caregiver (meaning a parent/guardian) for each adolescent.


Recruitment information / eligibility

Status Completed
Enrollment 1200
Est. completion date November 28, 2017
Est. primary completion date November 28, 2017
Accepts healthy volunteers No
Gender All
Age group 13 Years to 17 Years
Eligibility [The above age limits are specific to adolescent participants.]

Inclusion Criteria - Adolescents

- Between ages 13 and 17 (inclusive)

- Able to read and speak English

- Has recurring headaches that are not related to another medical condition

- iPhone user with access to an iPhone [4/4S or later] for use during the intervention period

Exclusion Criteria - Adolescents

- Secondary headache or seizure disorder. Examples include: increased intracranial pressure, hydrocephalus, traumatic brain injury, benign or cancerous brain

- Cognitive impairment or psychiatric condition that would interfere with ability to use the mobile application or complete the assessments

Inclusion Criteria - Caregivers

Parent or guardian of an adolescent who meets the above eligibility criteria for adolescent participants

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
pain self management app on smartphone


Locations

Country Name City State
United States Inflexxion Newton Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Stephen F Butler, PhD

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in pain coping at 2 months, 3 months, and 6 months post-baseline Measured by Pain Coping Questionnaire (PCQ) - Reid et al., 1998 2 months, 3 months, 6 months
Primary Change in headache intensity at 2 months, 3 months, and 6 months post-baseline "In the past 7 days, how would you rate your headache pain on average..." from 0-no pain to 10-worst possible pain 2 months, 3 months, 6 months
Primary Change in headache frequency at 2 months, 3 months, and 6 months post-baseline On how many days during the past 30 days have you had a headache? How many days in the past 30 were you completely headache free?" 2 months, 3 months, 6 months
Primary Change in quality of life at 2 months, 3 months, and 6 months post-baseline Measured by PedMIDAS - Hershey et al., 2001 2 months, 3 months, 6 months
Secondary Change in pain self-efficacy at 2 months, 3 months, and 6 months post-baseline Measured by Pain Self-Efficacy Scale - Burch, Tsao, et al., 2006 2 months, 3 months, 6 months
Secondary Change in school absenteeism at 2 months, 3 months, and 6 months post-baseline Ask caregivers: "How many full school days did your child miss in the past 30 days due to headaches?" 2 months, 3 months, 6 months
Secondary Change in physical and psychosocial functioning at at 2 months, 3 months, and 6 months post-baseline Measured by parent report version of the PedsQL 4.0 (Varni et al., 1999) 2 months, 3 months, 6 months
Secondary Change in health care utilization at 2 months, 3 months, and 6 months post-baseline Measured by asking caregiver to report information such as the following:
How many days in the past 30 days did his/her child see a healthcare provider for his/her headaches?
What types of treatment (including medications) has his/her child received for headaches in the past 30 days?
2 months, 3 months, 6 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care